MedTrace Logo

Comorbidity After Gastric Bypass

NCT02710786 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25000

Last updated 2023-12-26

No results posted yet for this study

Summary

To evaluate effect on comorbid disease and weight loss in the long-term (\>five years) after Roux-en-Y gastric bypass (RYGB) surgery for severe obesity.

Conditions

Interventions

PROCEDURE

Gastric bypass

Gastric bypass surgery, i.e., small gastric pouch and excluded main stomach

Sponsors & Collaborators

  • Karolinska Institutet

    collaborator OTHER

  • The Scandinavian Obesity Surgery Registry

    collaborator UNKNOWN

  • Uppsala University

    lead OTHER

Principal Investigators

  • Ingemar Näslund · Scandinavian Obesity Surgery Registry

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02710786 on ClinicalTrials.gov